These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 14966105)

  • 1. Dose density by any other name.
    Hryniuk W; Ragaz J; Peters W
    J Clin Oncol; 2004 Feb; 22(4):750-1; author reply 751-3. PubMed ID: 14966105
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved outcome with dose-dense chemotherapy.
    Keith B; Hall R; Scholnik A
    J Clin Oncol; 2004 Feb; 22(4):749; author rpely 751-3. PubMed ID: 14966104
    [No Abstract]   [Full Text] [Related]  

  • 3. [In search of Eldorado. Breast cancer and intensification therapy].
    Murillo Capitán E
    Med Clin (Barc); 1996 Jun; 107(3):95-8. PubMed ID: 8754496
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of carcinoma of the breast.
    Huguley CM
    J Med Assoc Ga; 1972 Dec; 61(12):402-3. PubMed ID: 4644928
    [No Abstract]   [Full Text] [Related]  

  • 5. Can a rational design for metronomic chemotherapy dosing be devised?
    Maraveyas A; Lam T; Hetherington JW; Greenman J
    Br J Cancer; 2005 Apr; 92(8):1588-90. PubMed ID: 15846302
    [No Abstract]   [Full Text] [Related]  

  • 6. Current status of dose-dense chemotherapy for breast cancer.
    Seidman AD
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():78-83. PubMed ID: 16273358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does paclitaxel decrease the interstitial fluid pressure and improve oxygenation in breast cancer in a schedule-dependent fashion?
    Altundag K; Altundag O; Turen S
    Med Hypotheses; 2005; 65(5):1002-3. PubMed ID: 15946804
    [No Abstract]   [Full Text] [Related]  

  • 8. How long?
    Sledge GW
    Clin Breast Cancer; 2008 Oct; 8(5):391. PubMed ID: 18952551
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose and schedule as determinants of outcomes in chemotherapy for breast cancer.
    Budman DR
    Semin Oncol; 2004 Dec; 31(6 Suppl 15):3-9. PubMed ID: 15726532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High-dosage treatment of breast cancer--in favour].
    Zander AR; Kröger N
    Dtsch Med Wochenschr; 2001 Sep; 126(39):1091. PubMed ID: 11602918
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose-dense chemotherapy for primary breast cancer.
    Kümmel S; Rezai M; Kimmig R; Schmid P
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):75-81. PubMed ID: 17218856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing chemotherapy for breast cancer: timing is everything.
    Hudis C
    J Clin Oncol; 2005 Aug; 23(24):5434-6. PubMed ID: 16110004
    [No Abstract]   [Full Text] [Related]  

  • 13. Is it feasible to adjust bisphosphonate dose according to bone mineral density value in postmenopausal breast cancer patients with bone metastases?
    Delibasi T; Akkus NI; Altundag O; Pinar T; Altundag K
    Med Hypotheses; 2006; 66(6):1254-5. PubMed ID: 16413688
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metastatic breast carcinoma. Saving quality of life with a staged plan].
    Kreutzberg K
    MMW Fortschr Med; 2000 Aug; 142(31-32):16-7. PubMed ID: 10992761
    [No Abstract]   [Full Text] [Related]  

  • 15. [High-dosage treatment of breast cancer - against].
    Hossfeld DK
    Dtsch Med Wochenschr; 2001 Sep; 126(39):1092. PubMed ID: 11602919
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances in the hormonal treatment of breast cancer.
    Boughey JC; Buzdar AU; Hunt KK
    Curr Probl Surg; 2008 Jan; 45(1):13-55. PubMed ID: 18206436
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163.
    Ellard SL; Clemons M; Gelmon KA; Norris B; Kennecke H; Chia S; Pritchard K; Eisen A; Vandenberg T; Taylor M; Sauerbrei E; Mishaeli M; Huntsman D; Walsh W; Olivo M; McIntosh L; Seymour L
    J Clin Oncol; 2009 Sep; 27(27):4536-41. PubMed ID: 19687332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of dose-dense chemotherapy in the management of breast cancer.
    Norton L
    Clin Adv Hematol Oncol; 2006 Jan; 4(1):36-7. PubMed ID: 16562368
    [No Abstract]   [Full Text] [Related]  

  • 19. Performing chemotherapy in proper menstrual stage for maximal efficacy in breast cancer.
    Ling W; Yonggang LV
    Med Hypotheses; 2009 Sep; 73(3):460-1. PubMed ID: 19409715
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients.
    J Support Oncol; 2006 Feb; 4(2):66-7. PubMed ID: 16499119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.